Britain’s leader sought to deflect criticism that he’s been working too closely with US drug maker Pfizer in its proposed $106-billion takeover of the Anglo-Swedish firm AstraZeneca.
With fears growing that British jobs will be lost and the nation’s science base undermined in the potential merger, Prime Minister David Cameron denied in a BBC interview today that he was favouring the American company.
When asked on The Andrew Marr Show whether he was engaging more closely with Pfizer, Cameron insisted that was not the case.
Cameron said “ministers were talking to AstraZeneca before anyone spoke to Pfizer.”
Pfizer has been trying to buy AstraZeneca since January, but has been rebuffed three times. The proposed deal would be the largest foreign takeover of a British company.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.